rs876657728
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_138691.3(TMC1):c.1676G>A(p.Trp559Ter) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000105 in 1,613,042 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_138691.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMC1 | NM_138691.3 | c.1676G>A | p.Trp559Ter | stop_gained | 18/24 | ENST00000297784.10 | NP_619636.2 | |
TMC1 | XM_017014256.2 | c.1679G>A | p.Trp560Ter | stop_gained | 15/21 | XP_016869745.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMC1 | ENST00000297784.10 | c.1676G>A | p.Trp559Ter | stop_gained | 18/24 | 1 | NM_138691.3 | ENSP00000297784 | P2 |
Frequencies
GnomAD3 genomes AF: 0.0000396 AC: 6AN: 151538Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000795 AC: 2AN: 251466Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135906
GnomAD4 exome AF: 0.00000753 AC: 11AN: 1461504Hom.: 0 Cov.: 31 AF XY: 0.0000110 AC XY: 8AN XY: 727076
GnomAD4 genome AF: 0.0000396 AC: 6AN: 151538Hom.: 0 Cov.: 32 AF XY: 0.0000406 AC XY: 3AN XY: 73966
ClinVar
Submissions by phenotype
not provided Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Athena Diagnostics | Jul 23, 2020 | The variant creates a premature nonsense codon, and is therefore predicted to result in the loss of a functional protein. Found in at least one patient with expected phenotype for this gene, and found in general population data at a frequency that is consistent with pathogenicity. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Sep 22, 2023 | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 29196752) - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 20, 2023 | This sequence change creates a premature translational stop signal (p.Trp559*) in the TMC1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TMC1 are known to be pathogenic (PMID: 11850618, 22105175). This variant is present in population databases (no rsID available, gnomAD 0.003%). This premature translational stop signal has been observed in individual(s) with congenital deafness (PMID: 29196752). ClinVar contains an entry for this variant (Variation ID: 228406). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. - |
Rare genetic deafness Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Dec 22, 2016 | The p.Trp559X variant in TMC1 has now been identified by our laboratory in 2 ind ividuals with hearing loss, and both of them have a second pathogenic variant in TMC1. This variant has not been identified in large population studies. This no nsense variant leads to a premature termination codon at position 559, which is predicted to lead to a truncated or absent protein. Loss of function variants af fecting both copies of TMC1 is an established disease mechanism for nonsyndromic autosomal recessive hearing loss. In summary, this variant meets criteria to be classified as pathogenic for hearing loss in an autosomal recessive manner base d upon the predicted impact of the variant. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at